{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:52:34Z","timestamp":1790189554019,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000254.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000}}],"reference-count":202,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000254.pub5","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T10:42:32Z","timestamp":1694601752000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration"],"prefix":"10.1002","volume":"2023","author":[{"given":"Jennifer R","family":"Evans","sequence":"additional","affiliation":[{"name":"Centre for Public Health; International Centre for Eye Health, London School of Hygiene & Tropical Medicine; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G","family":"Lawrenson","sequence":"additional","affiliation":[{"name":"Centre for Applied Vision Research, School of Health Sciences; City University of London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0001|cit1","first-page":"12","article-title":"Multicenter ophthalmic and nutritional age-related macular degeneration study - part 1: design, subjects and procedures","volume":"67","author":"Richer","year":"1996","journal-title":"Journal of the American Optometric Association"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0002|cit2","first-page":"30","article-title":"Multicenter ophthalmic and nutritional age-related macular degeneration study - part 2: antioxidant intervention and conclusions","volume":"67","author":"Richer","year":"1996","journal-title":"Journal of the American Optometry Association"},{"issue":"10","key":"10.1002\/14651858.CD000254.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","article-title":"The age-related eye disease study (AREDS) system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report no. 6","volume":"132","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jamaophthalmol.2013.6636","article-title":"Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","article-title":"Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35","volume":"120","author":"Chew","year":"2013","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.ophtha.2014.05.008","article-title":"No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archopht.122.5.716","article-title":"Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the age-related eye disease study: AREDS report no. 13","volume":"122","author":"Clemons","year":"2004","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.juro.2006.09.047","article-title":"High dose zinc increases hospital admissions due to genitourinary complications","volume":"177","author":"Johnson","year":"2007","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2006.09.056","article-title":"Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration","volume":"143","author":"Moriarty-Craige","year":"2007","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-2456(99)00031-8","article-title":"The age-related eye disease study (AREDS): design implications AREDS report no. 1","volume":"20","author":"The Age-Related Eye Disease Study Research Group","year":"1999","journal-title":"Controlled Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/jamaophthalmol.2020.0824","article-title":"Association of 2-year progression along the AREDS AMD scale and development of late age-related macular degeneration or loss of visual acuity: AREDS report 41","volume":"138","author":"Vitale","year":"2020","journal-title":"JAMA Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"19","key":"10.1002\/14651858.CD000254.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","author":"Age-Related Eye Disease Study 2 Research Group","year":"2013","journal-title":"JAMA"},{"issue":"13","key":"10.1002\/14651858.CD000254.pub5-BIB0015|cit15","first-page":"ARVO E","article-title":"Treatment response to AREDS components as a function of CFH and ARMS2 risk in patients with AMD","volume":"55","author":"Awh","year":"2014","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0016|cit16","first-page":"ARVO E","article-title":"Genetic interaction with response to oral micronutrient supplements in the Age-Related Eye Disease Study 2 (AREDS2)","volume":"58","author":"Chew","year":"2017","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The age-related eye disease study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"692\u20138","DOI":"10.1001\/jamaophthalmol.2022.1640","article-title":"Long-term outcomes of adding lutein\/zeaxanthin and \u03c9-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 Report 28","volume":"140","author":"Chew","year":"2022","journal-title":"JAMA Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0019|cit19","first-page":"ARVO E","article-title":"The results of the 10 year follow-on study of the Age-Related Eye Disease Study 2 (AREDS2)","volume":"62","author":"Chew","year":"2021","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1167\/iovs.07-1267","article-title":"Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2","volume":"49","author":"Hubbard","year":"2008","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0021|cit21","unstructured":"McBee WL Clemons TE Chew EY SanGiovanni JP An examination of site visit data audit results compiled during the initial four years of a long-term clinical trial Clinical Trials Conference: 32nd Meeting of the Society of Clinical Trials. 2011 May 15-18; Vancouver (BC) 2011"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ophtha.2017.10.028","article-title":"Association of mortality with ocular diseases and visual impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13","volume":"125","author":"Papudesu","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0023|cit23","unstructured":"Vitale S Agron E Clemons TE Domalpally A Danis RP Keenan TD Association of short-term progression in AMD score with risk of development of late AMD and vision loss in the AREDS2 study Investigative Ophthalmology and Visual Science 2019 60 9 ARVO E abstract 52"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jamainternmed.2014.328","article-title":"Effect of long-chain omega-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the age-related eye disease study 2 (AREDS2) randomized clinical trial","volume":"174","author":"Bonds","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jfo.2016.11.009","article-title":"Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam\u00ae 200 pigment module: impact of age-related macular degeneration and lens status","volume":"40","author":"Azar","year":"2017","journal-title":"Journal Fran\u00e7ais d'Ophtalmologie"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2891-2-12","article-title":"A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology","volume":"2","author":"Bartlett","year":"2003","journal-title":"Nutrition Journal"},{"issue":"9","key":"10.1002\/14651858.CD000254.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.ejcn.1602626","article-title":"Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial","volume":"61","author":"Bartlett","year":"2007","journal-title":"European Journal of Clinical Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1017\/S0007114512004187","article-title":"The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy - a randomised controlled trial","volume":"109","author":"Berrow","year":"2013","journal-title":"British Journal of Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ophtha.2012.08.040","article-title":"Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration","volume":"120","author":"Beatty","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ophtha.2012.09.013","article-title":"Visual outcome after antioxidant supplementation","volume":"120","author":"Beatty","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1097\/IAE.0b013e31820d3ed1","article-title":"Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter","volume":"31","author":"Lai","year":"2011","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/09286580802154275","article-title":"Carotenoids and co-antioxidants in age-related maculopathy: design and methods","volume":"15","author":"Neelam","year":"2008","journal-title":"Ophthalmic Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0033|cit33","first-page":"216","article-title":"Carotenoids in age-related maculopathy Italian study (CARMIS): two-year results of a randomized study","volume":"22","author":"Piermarocchi","year":"2011","journal-title":"European Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1167\/iovs.12-10715","article-title":"Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study","volume":"54","author":"Murray","year":"2013","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"e73387","DOI":"10.1371\/journal.pone.0073387","article-title":"The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d","volume":"8","author":"Tian","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0036|cit36","unstructured":"There is no publication for this study"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/nu13041253","article-title":"A randomized study of nutritional supplementation in patients with unilateral wet age-related macular degeneration","volume":"13","author":"Abraldes","year":"2021","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0038|cit38","first-page":"391","article-title":"Oral zinc-therapy in age-related macular degeneration: a double-blind study","volume":"2","author":"Holz","year":"1993","journal-title":"German Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000310646","article-title":"Visaline in the treatment of age-related macular degeneration: a pilot study","volume":"209","author":"Kaiser","year":"1995","journal-title":"Ophthalmologica"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.optm.2006.10.019","article-title":"LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls","volume":"78","author":"Richer","year":"2007","journal-title":"Optometry"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1529-1839(04)70049-4","article-title":"Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (lutein antioxidant supplementation trial)","volume":"75","author":"Richer","year":"2004","journal-title":"Optometry"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0042|cit42","first-page":"2109","article-title":"Effect of lutein intervention on visual function in patients with early age-related macular degeneration","volume":"17","author":"Li","year":"2017","journal-title":"International Eye Science"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0043|cit43","first-page":"970","article-title":"Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration","volume":"11","author":"Li","year":"2018","journal-title":"International Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0044|cit44","first-page":"605","article-title":"Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration","volume":"23","author":"Schmetterer","year":"2013","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Schmidl D Weigert G Kaya S Pemp B Sacu S Lasta M How lutein supplementation affects macular pigment optical density and visual acuity in patients with age related macular degeneration Joint Annual Meeting of the German, Swiss, and Austrian Societies for Clinical Pharmacology and Toxicology; 2011 Oct 20-22; Zurich, Switzerland British Journal of Clinical Pharmacology 2011","DOI":"10.1167\/iovs.11-7522"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1167\/iovs.11-7522","article-title":"Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration","volume":"52","author":"Weigert","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamaophthalmol.2013.2851","article-title":"Macular xanthophylls and omega-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial","volume":"131","author":"Arnold","year":"2013","journal-title":"JAMA Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00417-013-2376-6","article-title":"Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study","volume":"251","author":"Dawczynski","year":"2013","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0031-1273339","article-title":"Changes of macular pigment and drusen morphology in patients with lutein supplementation","volume":"229","author":"Dawczynski","year":"2012","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0050|cit50","first-page":"564738","article-title":"Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration","volume":"2015","author":"Huang","year":"2015","journal-title":"Biomed Research International"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bjophthalmol-2014-305503","article-title":"Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial","volume":"99","author":"Huang","year":"2015","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.nut.2012.06.009","article-title":"Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration","volume":"29","author":"Huang","year":"2013","journal-title":"Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ajo.2012.04.014","article-title":"Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial","volume":"154","author":"Ma","year":"2012","journal-title":"American Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.ophtha.2012.06.014","article-title":"Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration","volume":"119","author":"Ma","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0055|cit55","unstructured":"Effects of lutein and zeaxanthin supplementation on age-related macular degeneration clinicaltrials.gov\/ct2\/show\/NCT01048476"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archopht.1988.01060130202026","article-title":"Oral zinc in macular degeneration","volume":"106","author":"Newsome","year":"1988","journal-title":"Archives of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/02713680802178437","article-title":"A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration","volume":"33","author":"Newsome","year":"2008","journal-title":"Current Eye Research"},{"issue":"9","key":"10.1002\/14651858.CD000254.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s12325-019-01016-2","article-title":"Effects of Macuprev\u00ae supplementation in age-related macular degeneration: a double-blind randomized morpho-functional study along 6 months of follow-up","volume":"36","author":"Parravano","year":"2019","journal-title":"Advances in Therapy"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1120672119836007","article-title":"Effect of 2-year nutritional supplementation on progression of age-related macular degeneration","volume":"30","author":"Piatti","year":"2020","journal-title":"European Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0060|cit60","first-page":"1225","article-title":"Oral zinc and the second eye in age-related macular degeneration","volume":"37","author":"Stur","year":"1996","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1076\/opep.6.3.195.1500","article-title":"Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy","volume":"6","author":"Garrett","year":"1999","journal-title":"Ophthalmic Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-4356(99)00153-5","article-title":"Community-based recruitment strategies for a longitudinal interventional study: the VECAT experience","volume":"53","author":"Garrett","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1440-1606.1999.00240.x","article-title":"Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study","volume":"27","author":"Robman","year":"1999","journal-title":"Australian and New Zealand Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0064|cit64","first-page":"S311","article-title":"Vitamin E supplementation and age-related maculopathy","volume":"42","author":"Taylor","year":"2001","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1076\/opep.6.3.181.1502","article-title":"The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, cataract, and age-related maculopathy study","volume":"6","author":"Tikellis","year":"1999","journal-title":"Ophthalmic Epidemiology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0066|cit66","first-page":"1290","article-title":"Effects of zinc and antioxidant on visual function of patients with age-related macular degeneration","volume":"8","author":"Wang","year":"2004","journal-title":"Zhongguo Linchuant Kangfu"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/eye.2015.64","article-title":"Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration","volume":"29","author":"Akuffo","year":"2015","journal-title":"Eye"},{"issue":"1139","key":"10.1002\/14651858.CD000254.pub5-BIB0068|cit68","first-page":"60","article-title":"Eye health: the role of nutritional supplements in reducing the risk and progression of age-related macular degeneration","volume":"96","year":"2015","journal-title":"Australian Journal of Pharmacy"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2415-6-23","article-title":"Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial","volume":"6","author":"Bahrami","year":"2006","journal-title":"BMC Ophthalmology"},{"issue":"7-8","key":"10.1002\/14651858.CD000254.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/02713680600760501","article-title":"Effect of niacin on retinal vascular diameter in patients with age-related macular degeneration","volume":"31","author":"Barakat","year":"2006","journal-title":"Current Eye Research"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1079\/BJN20061796","article-title":"Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L)","volume":"96","author":"Benzie","year":"2006","journal-title":"British Journal of Nutrition"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0072|cit72","first-page":"ARVO E","article-title":"Consuming a buttermilk drink containing lutein-enriched egg-yolk daily for 1 year improves macular pigment optical density and visual acuity in subjects with early signs of age-related macular degeneration","volume":"56","author":"Berendschot","year":"2015","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1743-7075-4-12","article-title":"Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin","volume":"4","author":"Bone","year":"2007","journal-title":"Nutrition and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00417-018-4163-x","article-title":"Saffron therapy for the treatment of mild\/moderate age-related macular degeneration: a randomised clinical trial","volume":"257","author":"Broadhead","year":"2019","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2415-7-3","article-title":"TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD","volume":"7","author":"Cangemi","year":"2007","journal-title":"BMC Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archopht.125.3.333","article-title":"Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians","volume":"125","author":"Christen","year":"2007","journal-title":"Archives of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1167\/iovs.11-8025","article-title":"Supplementation with all three macular carotenoids: response, stability, and safety","volume":"52","author":"Connolly","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09286586.2014.888085","article-title":"Central retinal enrichment supplementation trials (CREST): design and methodology of the CREST randomized controlled trials","volume":"21","author":"Akuffo","year":"2014","journal-title":"Ophthalmic Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5414\/TEP23103","article-title":"Serum zinc and copper level in age-related macular degeneration","volume":"23","author":"Cumurcu","year":"2006","journal-title":"Trace Elements and Electrolytes"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1017\/S0007114516003895","article-title":"Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT)","volume":"117","author":"Kelly","year":"2017","journal-title":"British Journal of Nutrition"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1167\/iovs.09-4995","article-title":"Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration","volume":"51","author":"Falsini","year":"2010","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0082|cit82","first-page":"69","article-title":"Serum and macular responses to antioxidant supplementation versus a carotenoid-rich dietary intervention in the elderly","volume":"4","author":"Franciose","year":"2006","journal-title":"Current Topics in Nutraceuticals Research"},{"issue":"10","key":"10.1002\/14651858.CD000254.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/jn\/136.10.2519","article-title":"Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations","volume":"136","author":"Goodrow","year":"2006","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0084|cit84","unstructured":"Macular pigment and its contribution to visual performance and comfort controlled-trials.com\/ISRCTN35481392"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0085|cit85","unstructured":"Comparison of macular and serum responses after supplementation with two different macular carotenoid formulations controlled-trials.com\/ISRCTN81595685"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0086|cit86","unstructured":"Randomized parallel-group trial of lutein supplementation for macular pigment optical density and visual function in the patients with unilateral age-related macular degeneration www.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000027962"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00417-005-0108-2","article-title":"Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration","volume":"244","author":"Kamburoglu","year":"2006","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0088|cit88","first-page":"503","article-title":"Vitamins for age-related macular degeneration demonstrate minimal differences","volume":"59","author":"Kolber","year":"2013","journal-title":"Canadian Family Physician"},{"issue":"21","key":"10.1002\/14651858.CD000254.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1021\/jf0614802","article-title":"Spinach cultigen variation for tissue carotenoid concentrations influences human serum carotenoid levels and macular pigment optical density following a 12-week dietary intervention","volume":"54","author":"Kopsell","year":"2006","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.18388\/abp.2012_2198","article-title":"Comparison of dietary supplementation with lutein diacetate and lutein: a pilot study of the effects on serum and macular pigment","volume":"59","author":"Landrum","year":"2012","journal-title":"Acta Biochimica Polonica"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00006982-200603000-00010","article-title":"One-year results of a pilot study using oral 13-cis retinoic acid as a treatment for subfoveal predominantly occult choroidal neovascularization in patients with age-related macular degeneration","volume":"26","author":"Lim","year":"2006","journal-title":"Retina"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jamaophthalmol.2017.3398","article-title":"Effect of dietary supplementation with lutein, zeaxanthin, and \u03c9-3 on macular pigment: a randomized clinical trial","volume":"135","author":"Korobelnik","year":"2017","journal-title":"JAMA Ophthalmology"},{"issue":"15","key":"10.1002\/14651858.CD000254.pub5-BIB0093|cit93","first-page":"ARVO E","article-title":"A randomized trial of supplementation with lutein, zeaxanthin, omega 3 fatty acids and antioxidants for increasing macular pigment optical density in high-risk subjects: the LIMPIA Study","volume":"54","author":"Korobelnik","year":"2013","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2006.12.010","article-title":"Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study","volume":"84","author":"Trieschmann","year":"2007","journal-title":"Experimental Eye Research"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1167\/iovs.12-9713","article-title":"Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA study","volume":"53","author":"Zeimer","year":"2012","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1475-1313.2006.00387.x","article-title":"Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance","volume":"26","author":"Kvansakul","year":"2006","journal-title":"Ophthalmic and Physiological Optics"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1475-1313.2006.00386.x","article-title":"The effects of supplementation with lutein and\/or zeaxanthin on human macular pigment density and colour vision","volume":"26","author":"Rodriguez-Carmona","year":"2006","journal-title":"Ophthalmic and Physiological Optics"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.abb.2006.09.032","article-title":"Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (lutein xanthophyll eye accumulation) study","volume":"458","author":"Schalch","year":"2007","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0099|cit99","first-page":"604","article-title":"Macular response to supplementation with differing carotenoid formulations in subjects with and without age-related macular degeneration","volume":"23","author":"Meagher","year":"2013","journal-title":"European Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archopht.124.8.1151","article-title":"Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the carotenoids in age-related eye disease study (CAREDS): ancillary study of the women's health initiative","volume":"124","author":"Moeller","year":"2006","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0101|cit101","unstructured":"Lutein\/zeaxanthin and omega-3 supplementation in persons over age 60 clinicaltrials.gov\/ct2\/show\/NCT00121589"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0102|cit102","unstructured":"Effects of antioxidants on human macular pigments clinicaltrials.gov\/ct2\/show\/NCT00718653"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0103|cit103","unstructured":"Superoxide Dismutase (SOD) as antioxidant treatment of age related macular degeneration (ARMD) clinicaltrials.gov\/ct2\/show\/NCT00800995"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0104|cit104","unstructured":"Supplemental adjuvants for intracellular nutrition and treatment (SAINTS) clinicaltrials.gov\/ct2\/show\/NCT00893724"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0105|cit105","unstructured":"Drusen morphology changes in nonexudative age-related degeneration after oral antioxidants supplementation clinicaltrials.gov\/ct2\/show\/NCT02264938"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0106|cit106","unstructured":"Cataract and AMD in a trial of a multivitamin and cocoa extract (COSMOS-Eye) clinicaltrials.gov\/ct2\/show\/NCT03205202"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0107|cit107","unstructured":"Vitamin A palmitate supplementation in people with age-related macular degeneration (and without reticular pPseudodrusen) and delayed dark adaptation clinicaltrials.gov\/ct2\/show\/NCT03478865"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02713680500514677","article-title":"Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin","volume":"31","author":"Nolan","year":"2006","journal-title":"Current Eye Research"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.exer.2006.08.016","article-title":"Risk factors for age-related maculopathy are associated with a relative lack of macular pigment","volume":"84","author":"Nolan","year":"2007","journal-title":"Experimental Eye Research"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2012.05.006","article-title":"Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment","volume":"101","author":"Nolan","year":"2012","journal-title":"Experimental Eye Research"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2005.07.036","article-title":"Vitamin E in the treatment of uveitis-associated macular edema","volume":"141","author":"Nussenblatt","year":"2006","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1167\/iovs.05-1292","article-title":"Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy","volume":"47","author":"Owsley","year":"2006","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ophtha.2013.09.038","article-title":"Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians","volume":"121","author":"Christen","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.ophtha.2012.01.053","article-title":"Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians","volume":"119","author":"Christen","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1167\/iovs.06-0504","article-title":"The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older","volume":"47","author":"Khachik","year":"2006","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1167\/iovs.05-1513","article-title":"Dose-ranging study of lutein supplementation in persons aged 60 years or older","volume":"47","author":"Rosenthal","year":"2006","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"9","key":"10.1002\/14651858.CD000254.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/IAE.0000000000000174","article-title":"Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration","volume":"34","author":"Sabour-Pickett","year":"2014","journal-title":"Retina"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0118|cit118","unstructured":"Saperstein DA Pieramici DJ Sall KN Heier JS Brown DM Birch DG Clinical proof-of-concept study of oral synthetic cis-retinoid (QLT091001) in adult subjects with impaired dark adaptation and\/or impaired low luminance vision Investigative Ophthalmology and Visual Science 2015 56 7 ARVO E abstract 3791"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00417-011-1780-z","article-title":"Effect of 1-year lutein supplementation on macular pigment optical density and visual function","volume":"249","author":"Sasamoto","year":"2011","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0008-4182(02)80042-4","article-title":"Photodynamic therapy for age related macular degeneration with and without antioxidants","volume":"37","author":"Scorolli","year":"2002","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.ophtha.2013.01.005","article-title":"Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD treatment 2 study","volume":"120","author":"Souied","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1167\/iovs.13-13784","article-title":"Retinal hemodynamic effects of antioxidant supplementation in an endotoxin-induced model of oxidative stress in humans","volume":"55","author":"Told","year":"2014","journal-title":"Investigative Ophthalmology and Vision Science"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1167\/iovs.14-15581","article-title":"Antioxidative capacity of a dietary supplement on retinal hemodynamic function in a human lipopolysaccharide (LPS) model","volume":"56","author":"Told","year":"2015","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1755-3768.1958.tb00843.x","article-title":"On the treatment of arteriosclerotic chorioretinopathy","volume":"36","author":"Vannas","year":"1958","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1744-1161(11)70341-6","article-title":"Effect of a milk-based wolfberry preparation on immune function and physical status of elderly","volume":"6","author":"Vidal","year":"2011","journal-title":"Clinical Nutrition Supplements"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ajcn\/85.3.762","article-title":"Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration","volume":"85","author":"Wang","year":"2007","journal-title":"American Journal of Clinical Nutrition"},{"issue":"10","key":"10.1002\/14651858.CD000254.pub5-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1093\/jn\/136.10.2568","article-title":"A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women","volume":"136","author":"Wenzel","year":"2006","journal-title":"Journal of Nutrition"},{"issue":"13","key":"10.1002\/14651858.CD000254.pub5-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1167\/iovs.15-17586","article-title":"Oral lutein supplementation enhances macular pigment density and contrast sensitivity but not in combination with polyunsaturated fatty acids","volume":"56","author":"Wolf-Schnurrbusch","year":"2015","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1167\/iovs.10-5637","article-title":"Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial","volume":"51","author":"Wong","year":"2010","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0130|cit130","first-page":"53","article-title":"Carotenoids and ocular health","volume":"4","author":"Zhao","year":"2006","journal-title":"Current Topics in Nutraceuticals Research"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0131|cit131","unstructured":"The zeaxanthin and visual function study (ZVF) clinicaltrials.gov\/ct2\/show\/NCT00564902"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.optm.2011.08.008","article-title":"Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973","volume":"82","author":"Richer","year":"2011","journal-title":"Optometry"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0133|cit133","unstructured":"Chiosi F Minutillo E Rinaldi M Gallo O Manzi G The anti-oxidant effect of vitamin D and homotaurine on progression of early-intermediate age-related macular degeneration Investigative Ophthalmology and Visual Science 2020 61 7 ARVO E abstract 1789"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0134|cit134","unstructured":"Intervention trial in early age-related macular degeneration (I-TEAM) clinicaltrials.gov\/ct2\/show\/NCT01694680"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0135|cit135","unstructured":"Resveratrol for exudative age-related macular degeneration (AGED) clinicaltrials.gov\/ct2\/show\/NCT02625376"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0136|cit136","unstructured":"Phase 3 study of ALK-001 in geographic atrophy (SAGA) clinicaltrials.gov\/ct2\/show\/NCT03845582"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000357528","article-title":"Evidence-based nutritional advice for patients affected by age-related macular degeneration","volume":"231","author":"Andreatta","year":"2014","journal-title":"Ophthalmologica"},{"issue":"14","key":"10.1002\/14651858.CD000254.pub5-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1080\/10408398.2014.912199","article-title":"Efficacy of multivitamin\/mineral supplementation to reduce chronic disease risk: a critical review of the evidence from observational studies and randomized controlled trials","volume":"55","author":"Angelo","year":"2015","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lutein\/zeaxanthinon age-related macular degeneration progression AREDS2 Report No. 3","volume":"132","author":"The Age-Related Eye Disease Study 2 (AREDS2) Research Group","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2017.09.008","article-title":"Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in patients with age-related macular degeneration: independent statistical evaluations of data from the Age-Related Eye Disease Study","volume":"125","author":"Assel","year":"2018","journal-title":"Ophthalmology"},{"issue":"15","key":"10.1002\/14651858.CD000254.pub5-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199404143301501","article-title":"The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers","volume":"330","author":"Beta Carotene Cancer Prevention Study Group","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2013.07.039","article-title":"CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration","volume":"120","author":"Awh","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ophtha.2014.07.049","article-title":"Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study","volume":"122","author":"Awh","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mam.2017.06.004","article-title":"Many tocopherols, one vitamin E","volume":"61","author":"Azzi","year":"2018","journal-title":"Molecular Aspects of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007176.pub2","article-title":"Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases","author":"Bjelakovic","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/nutrit\/nuv005","article-title":"Dietary modification and supplementation for the treatment of age-related macular degeneration","volume":"73","author":"Broadhead","year":"2015","journal-title":"Nutrition Reviews"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/eye.2010.122","article-title":"Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008","volume":"24","author":"Bunce","year":"2010","journal-title":"Eye"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/OPTH.S59724","article-title":"Recent developments in the management of dry age-related macular degeneration","volume":"9","author":"Buschini","year":"2015","journal-title":"Clinical Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1350-9462(99)00009-9","article-title":"Oxidative damage and protection of the RPE","volume":"19","author":"Cai","year":"2000","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"Article ID 6469","DOI":"10.1155\/2017\/6469138","article-title":"Nutritional and lifestyle interventions for age-related macular degeneration: a review","volume":"2017","author":"Carneiro","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamaophthalmol.2014.643","article-title":"Vitamins and minerals, for eyes only?","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.ophtha.2014.05.008","article-title":"No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ophtha.2014.10.012","article-title":"Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?","volume":"122","author":"Chew","year":"2015","journal-title":"Ophthalmology"},{"issue":"7623","key":"10.1002\/14651858.CD000254.pub5-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/bmj.39350.500428.47","article-title":"Dietary antioxidants and primary prevention of age-related macular degeneration: systematic review and meta-analysis","volume":"335","author":"Chong","year":"2007","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/1047-2797(95)00094-1","article-title":"Antioxidants and age-related eye disease. Current and future perspectives","volume":"6","author":"Christen","year":"1996","journal-title":"Annals of Epidemiology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0156|cit156","unstructured":"Covidence Veritas Health Innovation"},{"issue":"20","key":"10.1002\/14651858.CD000254.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/nu14204273","article-title":"The effect of dietary supplementations on delaying the progression of age-related macular degeneration: a sytematic review and meta-analysis","volume":"14","author":"Csader","year":"2022","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0158|cit158","unstructured":"Deeks JJ Higgins JP on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/OPX.0000000000000285","article-title":"Nutrition and age-related macular degeneration: research evidence in practice","volume":"91","author":"Downie","year":"2014","journal-title":"Optometry and Vision Science"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0160|cit160","volume-title":"Early Treatment Diabetic Retinopathy Study Manual of Operations","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1980"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0161|cit161","unstructured":"European Food Safety Authority Dietary reference values www.efsa.europa.eu\/en\/topics\/topic\/dietary-reference-values"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Wilkinson","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/nutrit\/nuab038","article-title":"An appraisal of trials investigating the effects on macular pigment optical density of lutein and zeaxanthin dietary interventions: a narrative review","volume":"80","author":"Fitzpatrick","year":"2022","journal-title":"Nutrition Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000316476","article-title":"Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration","volume":"44","author":"Fletcher","year":"2010","journal-title":"Ophthalmic Research"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0165|cit165","unstructured":"Food and Agriculture Organization of the United Nations (FAO)\/World Health Organization (WHO) expert consultation Human Vitamin and Mineral Requirements: Report of a Joint FAO\/WHO Expert Consultation; Bangkok, Thailand; 2001 Available at: www.fao.org\/3\/y2809e\/y2809e00.pdf"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0166|cit166","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0167|cit167","unstructured":"GRADEpro McMaster University (developed by Evidence Prime)"},{"issue":"1-2","key":"10.1002\/14651858.CD000254.pub5-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-013-1908-z","article-title":"Antioxidants and vision health: facts and fiction","volume":"388","author":"Grover","year":"2014","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/bjophthalmol-2015-306972","article-title":"Current therapeutic developments in atrophic age-related macular degeneration","volume":"100","author":"Hanus","year":"2016","journal-title":"British Journal of Ophthalmology"},{"issue":"7414","key":"10.1002\/14651858.CD000254.pub5-BIB0170|cit170","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0171|cit171","doi-asserted-by":"crossref","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604.ch8"},{"issue":"5","key":"10.1002\/14651858.CD000254.pub5-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-145-5-200609050-00135","article-title":"The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference","volume":"145","author":"Huang","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0173|cit173","volume-title":"Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Available at nap.nationalacademies.org\/9810","author":"Institute of Medicine","year":"2000"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0174|cit174","volume-title":"Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum,Nickel, Silicon, Vanadium, and Zinc. Available at nap.nationalacademies.org\/10026","author":"Institute of Medicine","year":"2001"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","article-title":"Prevalence of age-related maculopathy. The beaver dam eye study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.ophtha.2008.01.036.","article-title":"CFH and LOC387715\/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration","volume":"115","author":"Klein","year":"2008","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD000254.pub5-BIB0177|cit177","first-page":"1196","article-title":"Core outcomes for geographic atrophy trials","volume":"104","author":"Krezel","year":"2020","journal-title":"BritishJournal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0178|cit178","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010015.pub3","article-title":"Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration","author":"Lawrenson","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1167\/iovs.14-15553","article-title":"Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration","volume":"56","author":"Liu","year":"2016","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"6","key":"10.1002\/14651858.CD000254.pub5-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21037\/atm-22-173","article-title":"The level and efficacy of lutein in patients with age-related macular degeneration: a comprehensive systematic review and meta-analysis","volume":"10","author":"Liu","year":"2022","journal-title":"Annals of Translational Medicine"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.fitote.2015.12.009","article-title":"Zeaxanthin and ocular health, from bench to bedside","volume":"109","author":"Manikandan","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0183|cit183","unstructured":"National Eye Institute AREDS 2 supplements for age-related macular degeneration (AMD) www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/age-related-macular-degeneration\/nutritional-supplements-age-related-macular-degeneration"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0184|cit184","unstructured":"National Institute for Health and Care Excellence (NICE) Age-related macular degeneration. NICE guideline NG82; January 2018 www.nice.org.uk\/guidance\/ng82"},{"issue":"18","key":"10.1002\/14651858.CD000254.pub5-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM199605023341802","article-title":"Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease","volume":"334","author":"Omenn","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000254.pub5-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1111\/aos.15191","article-title":"What did we learn in 35\u2009years of research on nutrition and supplements for age-related macular degeneration: a systematic review","volume":"100","author":"Pameijer","year":"2022","journal-title":"Acta Ophthalmologica"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jtemb.2014.07.019","article-title":"Zinc: an antioxidant and anti-inflammatory agent: role of zinc in degenerative disorders of aging","volume":"28","author":"Prasad","year":"2014","journal-title":"Journal of Trace Elements in Medicine and Biology"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0188|cit188","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2023"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2016.04.012","article-title":"Defining a minimum set of standardized patient-centered outcome measures for macular degeneration","volume":"168","author":"Rodrigues","year":"2016","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD000254.pub5-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD000254.pub5-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40123-017-0086-6","article-title":"A review of current and future management of geographic atrophy","volume":"6","author":"Sacconi","year":"2017","journal-title":"Ophthalmology and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/aos.12650","article-title":"Nutritional supplements in age-related macular degeneration","volume":"93","author":"Schmidl","year":"2015","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0193|cit193","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from handbook.cochrane.org","DOI":"10.1002\/9781119536604.ch14"},{"issue":"12","key":"10.1002\/14651858.CD000254.pub5-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-308624","article-title":"Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis","volume":"100","author":"Seddon","year":"2016","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD000254.pub5-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"E696","DOI":"10.1073\/pnas.1718059115","article-title":"CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation","volume":"115","author":"Vavvas","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"849\u201357","DOI":"10.1038\/eye.2017.245","article-title":"Genetics and genetic testing for age-related macular degeneration","volume":"32","author":"Warwick","year":"2018","journal-title":"Eye"},{"issue":"27","key":"10.1002\/14651858.CD000254.pub5-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22270","article-title":"Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review","volume":"22","author":"Waugh","year":"2018","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD000254.pub5-BIB0198|cit198","volume-title":"Dietary reference intakes. Proposed definition and plan for review of dietary antioxidant and related compounds","author":"Young","year":"1998"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nutres.2013.10.011","article-title":"Review of nutrient actions on age-related macular degeneration","volume":"34","author":"Zampatti","year":"2014","journal-title":"Nutrition Research"},{"issue":"2","key":"10.1002\/14651858.CD000254.pub5-BIB0200|cit200","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000254.pub2","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration","author":"Evans","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD000254.pub5-BIB0201|cit201","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000254.pub3","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration","author":"Evans","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD000254.pub5-BIB0202|cit202","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000254.pub4","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration","author":"Evans","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:03:35Z","timestamp":1747119815000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000254.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":202,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000254.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]}}}